| 초록 |
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, and characterized
by age-dependent occurrence of bilateral and multiple renal cysts as well as extrarenal manifestations. The
discovery of the genes and their respective proteins that are associated with ADPKD has revolutionized the field of
ADPKD biology. Dominantly inherited gene muations followed by somatic hit mutations result in renal tubular cyst formation
and renal failure eventually. Mutations in two genes, PKD1 and PKD2, are responsible for ADPKD. The respective
gene products, polycystin-1 and polycystin-2, have been localized to the primary cilium. Recent studies indicate that
the pathogenesis of ADPKD is linked to abnormalities in the primary cilium in the kidney. Inactivation of ciliary proteins
in the postnatal kidney has uncovered novel roles of primary cilia in regulating tubular growth and repair after injury.
Furthermore, defective tubular repair after injury may contribute to the progression of ADPKD. Studies of signaling
pathways that are perturbed in ADPKD have identified potential targets for pharmacological therapy. Better understanding
of the downstream consequences of ADPKD mutations has identified a number of therapeutic targets that are now being
tested in preclinical and clinical trials. The author summarized recent insights in the pathogenesis of ADPKD including
the genetics of ADPKD, the properties of the respective polycystin proteins, the role of cilia, some cell signaling pathways
and new therapeutic interventions. |